Boston Biotech Awarded Best Pharmaceutical Consultants of Cambridge Award

CAMBRIDGE, Mass. - July 10, 2015 - PRLog -- Boston Biotech Clinical Research, the world’s first Strategic Clinical Innovation Organization (SCIO) has been selected 2015 Best Pharmaceutical Consultants by the Cambridge Award Program.  This is the third straight year that the company has received this honor.

“Cambridge is the East Coast’s epicenter of medical and biotech innovation,” said Candida Fratazzi MD, President. “Boston Biotech is honored to be recognized as a driver of innovation.”

Boston Biotech’s strategic approach to clinical development provides, with a one-time intervention, a cost-effective clinical plan, innovative study protocol, and regulatory strategy.  Clients utilize Boston Biotech’s MD consultants to provide a blueprint to their CRO (Clinical Research Organization) to ensure that patient selection, clinical endpoints, and product mechanism of action are aligned for success.

“Boston Biotech has a proven track record of shaving at least one month off the timeline from clinical trial timeline,” said Kristen Gleason, Director of Business Development.  “Industry statistics indicate that the average daily cost of clinical development is ~$0.5 million and the average peak revenue sales is ~$1.1m per day.  Boston Biotech is here to provide a strategic plan to reduce time to market.”[1]

About Boston Biotech

Boston Biotech Clinical Research (BBCR) is a strategic clinical innovation organization (SCIO) (http://www.bostonclinicalresearch.com/scio-concept/) that offers simplified, customized strategies to clinical development. BBCR has strong expertise in clinical and regulatory planning and knows how to drive to clinical trial success. BBCR helps biotech, pharmaceutical and device companies to deliver capital- and time-efficient clinical programs meeting the requirements of investors, partners and regulators.  For more information, visit: www.bostonclinicalresearch.com

Media Contact:

Kristen Gleason

kristen@bostonclinicalresearch.com

[1] The New Reality: Maximizing Product Launches in the Post-Blockbuster World; Accenture 2012

Paul SM, et al. Nat Rev Drug Discov. 2010;9(3):203-14